Redpoint Investment Management’s Boston Scientific BSX Stock Holding History

Redpoint Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.25M	Sell	32,389 -5,666	-15%	-$227K	0.18%	137
2022 Q2	$1.42M	Buy	38,055 +2,503	+7%	+$102K	0.17%	148
2022 Q1	$1.57M	Hold	35,552	–	–	0.16%	149
2021 Q4	$1.51M	Hold	35,552	–	–	0.12%	193
2021 Q3	$1.54M	Sell	35,552 -2,356	-6%	-$104K	0.13%	184
2021 Q2	$1.62M	Hold	37,908	–	–	0.13%	187
2021 Q1	$1.47M	Hold	37,908	–	–	0.12%	196
2020 Q4	$1.36M	Buy	37,908 +881	+2%	+$31.8K	0.14%	167
2020 Q3	$1.42M	Sell	37,027 -59,088	-61%	-$2.28M	0.15%	157
2020 Q2	$3.38M	Sell	96,115 -7,466	-7%	-$269K	0.19%	129
2020 Q1	$3.38M	Hold	103,581	–	–	0.21%	116
2019 Q4	$4.68M	Sell	103,581 -2,106	-2%	-$88.1K	0.23%	109
2019 Q3	$4.3M	Sell	105,687 -3,537	-3%	-$150K	0.23%	105
2019 Q2	$4.69M	Sell	109,224 -7,027	-6%	-$270K	0.25%	98
2019 Q1	$4.46M	Buy	116,251 +12,678	+12%	+$484K	0.22%	108
2018 Q4	$3.66M	Buy	103,573 +4,411	+4%	+$160K	0.21%	120
2018 Q3	$3.82M	Hold	99,162	–	–	0.19%	138
2018 Q2	$3.24M	Buy	99,162 +2,235	+2%	+$67.4K	0.18%	161
2018 Q1	$2.65M	Hold	96,927	–	–	0.15%	202
2017 Q4	$2.4M	Buy	+96,927	New	+$2.67M	0.13%	214

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Redpoint Investment Management's BSX Position: Q3 2022 in Review

Redpoint Investment Management reduced its Boston Scientific (BSX) stake by 15% in Q3 2022, selling an estimated $227K and leaving 32,389 shares worth $1.25M. The position accounts for 0.18% of the portfolio, ranked #137.

Redpoint Investment Management first reported a position in BSX in Q4 2017 and has held it in 20 quarters since. The position peaked at $4.69M in Q2 2019. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Redpoint Investment Management held 32,389 shares of Boston Scientific worth $1.25M as of Q3 2022.
Redpoint Investment Management sold 5,666 Boston Scientific shares in Q3 2022, an estimated $227K.
Boston Scientific made up 0.18% of Redpoint Investment Management's portfolio in Q3 2022, its #137 holding.
Redpoint Investment Management first reported a position in Boston Scientific in Q4 2017 and has held it in 20 quarters since.
Redpoint Investment Management's Boston Scientific position peaked at $4.69M in Q2 2019.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.